Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intravenous Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth in Women With Prenatal Depression: 3-year Follow-up of a Randomized Controlled Trial

NCT05698394 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05698394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05698394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intravenous Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth in Women With Prenatal Depression: 3-year Follow-up of a Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 9, 2023
Completion date
November 30, 2025
Enrollment
364 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ketamine, postpartum depression, prenatal depression